Cargando…

Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome

BACKGROUND: Aneurysmal subarachnoid hemorrhage is a life-threatening disease requiring neurocritical care. Delayed cerebral ischemia is a well-known complication that contributes to unfavorable neurological outcomes. Cerebral vasospasm has been thought to be the main cause of delayed cerebral ischem...

Descripción completa

Detalles Bibliográficos
Autores principales: Okazaki, Tomoya, Kuroda, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941608/
https://www.ncbi.nlm.nih.gov/pubmed/29760928
http://dx.doi.org/10.1186/s40560-018-0297-5
_version_ 1783321320011857920
author Okazaki, Tomoya
Kuroda, Yasuhiro
author_facet Okazaki, Tomoya
Kuroda, Yasuhiro
author_sort Okazaki, Tomoya
collection PubMed
description BACKGROUND: Aneurysmal subarachnoid hemorrhage is a life-threatening disease requiring neurocritical care. Delayed cerebral ischemia is a well-known complication that contributes to unfavorable neurological outcomes. Cerebral vasospasm has been thought to be the main cause of delayed cerebral ischemia, and although several studies were able to decrease cerebral vasospasm, none showed improved neurological outcomes. Our target is not cerebral vasospasm but improving neurological outcomes. The purpose of this review is to discuss what intensivists should know and can do to improve clinical outcomes in subarachnoid hemorrhage patients. MAIN BODY OF THE ABSTRACT: Delayed cerebral ischemia is thought to be due to not only vasospasm but also multifactorial mechanisms. Additionally, the concept of early brain injury, which occurs within the first 72 h after the hemorrhage, has become an important concern. Increasing sympathetic activity after the hemorrhage is associated with cardiopulmonary complications and poor outcomes. Serum lactate measurement may be a valuable marker reflecting the severity of sympathetic activity. The transpulmonary thermodilution method will bring about an advanced understanding of hemodynamic management. Fever is a well-recognized symptom and targeted temperature management is an anticipated intervention. To avoid hyperglycemia and hypoglycemia, performing moderate glucose control and minimizing glucose variability are important concepts in glycemic management, but the optimal target range remains unknown. Dysnatremia seems to be associated with negative outcomes. It is not clear yet that maintaining normonatremia actively improves neurological outcomes. Optimal duration of intensive care management has not been determined. SHORT CONCLUSION: Although we have an advanced understanding of the pathophysiology and clinical characteristics of subarachnoid hemorrhage, there are many controversies in the intensive care unit management of subarachnoid hemorrhage. With an awareness of not only delayed cerebral ischemia but also early brain injury, more attention should be given to various aspects to improve neurological outcomes.
format Online
Article
Text
id pubmed-5941608
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59416082018-05-14 Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome Okazaki, Tomoya Kuroda, Yasuhiro J Intensive Care Review BACKGROUND: Aneurysmal subarachnoid hemorrhage is a life-threatening disease requiring neurocritical care. Delayed cerebral ischemia is a well-known complication that contributes to unfavorable neurological outcomes. Cerebral vasospasm has been thought to be the main cause of delayed cerebral ischemia, and although several studies were able to decrease cerebral vasospasm, none showed improved neurological outcomes. Our target is not cerebral vasospasm but improving neurological outcomes. The purpose of this review is to discuss what intensivists should know and can do to improve clinical outcomes in subarachnoid hemorrhage patients. MAIN BODY OF THE ABSTRACT: Delayed cerebral ischemia is thought to be due to not only vasospasm but also multifactorial mechanisms. Additionally, the concept of early brain injury, which occurs within the first 72 h after the hemorrhage, has become an important concern. Increasing sympathetic activity after the hemorrhage is associated with cardiopulmonary complications and poor outcomes. Serum lactate measurement may be a valuable marker reflecting the severity of sympathetic activity. The transpulmonary thermodilution method will bring about an advanced understanding of hemodynamic management. Fever is a well-recognized symptom and targeted temperature management is an anticipated intervention. To avoid hyperglycemia and hypoglycemia, performing moderate glucose control and minimizing glucose variability are important concepts in glycemic management, but the optimal target range remains unknown. Dysnatremia seems to be associated with negative outcomes. It is not clear yet that maintaining normonatremia actively improves neurological outcomes. Optimal duration of intensive care management has not been determined. SHORT CONCLUSION: Although we have an advanced understanding of the pathophysiology and clinical characteristics of subarachnoid hemorrhage, there are many controversies in the intensive care unit management of subarachnoid hemorrhage. With an awareness of not only delayed cerebral ischemia but also early brain injury, more attention should be given to various aspects to improve neurological outcomes. BioMed Central 2018-05-08 /pmc/articles/PMC5941608/ /pubmed/29760928 http://dx.doi.org/10.1186/s40560-018-0297-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Okazaki, Tomoya
Kuroda, Yasuhiro
Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome
title Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome
title_full Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome
title_fullStr Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome
title_full_unstemmed Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome
title_short Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome
title_sort aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941608/
https://www.ncbi.nlm.nih.gov/pubmed/29760928
http://dx.doi.org/10.1186/s40560-018-0297-5
work_keys_str_mv AT okazakitomoya aneurysmalsubarachnoidhemorrhageintensivecareforimprovingneurologicaloutcome
AT kurodayasuhiro aneurysmalsubarachnoidhemorrhageintensivecareforimprovingneurologicaloutcome